تقرير
Tuberculosis treatment-related lichenoid drug eruptions.
| العنوان: | Tuberculosis treatment-related lichenoid drug eruptions. |
|---|---|
| المؤلفون: | Katran ZY; Department of Allergy and Immunology, University of Health Sciences, Süreyyapasa Training and Research Hospital, Istanbul, Turkey., Bulut I; Department of Allergy and Immunology, University of Health Sciences, Süreyyapasa Training and Research Hospital, Istanbul, Turkey., Babalık A; Department of Chest Diseases, University of Health Sciences, Süreyyapasa Training and Research Hospital, Istanbul, Turkey. |
| المصدر: | International journal of mycobacteriology [Int J Mycobacteriol] 2022 Oct-Dec; Vol. 11 (4), pp. 469-471. |
| نوع المنشور: | Case Reports |
| اللغة: | English |
| بيانات الدورية: | Publisher: Medknow Country of Publication: India NLM ID: 101615660 Publication Model: Print Cited Medium: Internet ISSN: 2212-554X (Electronic) Linking ISSN: 22125531 NLM ISO Abbreviation: Int J Mycobacteriol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2017>- : Mumbai, Maharashtra, India : Medknow Original Publication: Amsterdam : Elsevier, [2012]- |
| مواضيع طبية MeSH: | Tuberculosis*/drug therapy , Drug Eruptions*/drug therapy, Adult ; Humans ; Antitubercular Agents/adverse effects ; Pyrazinamide/therapeutic use ; Isoniazid/adverse effects |
| مستخلص: | Tuberculosis is one of the leading causes of death from infectious diseases in adults worldwide. Drug hypersensitivity in tuberculosis is an important problem affecting the treatment process. Although treatment is started with isoniazid, rifampicin, ethambutol, and pyrazinamide in drug-sensitive tuberculosis patients, it may not always be continued in this way. When hypersensitivity develops under antituberculosis treatment, type 4 hypersensitivity is the most common, and maculopapular drug eruption develops as a subgroup. Lichenoid drug eruption is very rare. We present our case who was diagnosed with pulmonary tuberculosis, who developed lichenoid drug eruption while receiving treatment, and whose treatment was completed by giving the new regimen with successful desensitization. Competing Interests: None |
| فهرسة مساهمة: | Keywords: Drug hypersensitivity; lichenoid drug eruptions; tuberculosis |
| المشرفين على المادة: | 0 (Antitubercular Agents) 2KNI5N06TI (Pyrazinamide) V83O1VOZ8L (Isoniazid) |
| تواريخ الأحداث: | Date Created: 20221213 Date Completed: 20221214 Latest Revision: 20230103 |
| رمز التحديث: | 20231215 |
| DOI: | 10.4103/ijmy.ijmy_151_22 |
| PMID: | 36510939 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2212-554X |
|---|---|
| DOI: | 10.4103/ijmy.ijmy_151_22 |